We split six vials four ways and posted them
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 18 of 48 of this archive, newest first.
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Follow the resin, not the catalogue.
A reminder that a purity figure is the output of a method, and that methods differ.
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
The result is unremarkable. What the report states alongside it is not.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
A manufacturer’s certificate is a self-declaration. An accredited laboratory’s report is a third-party measurement. The trade prints both under one heading.
The route did not close because of a rule about peptides.
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.
Nothing on this page is difficult. It is simply unfamiliar, and unfamiliarity is what makes a weak certificate look like a strong one.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.